Abstract
1914P Nintedanib(N) as switch maintenance treatment in malignant pleural mesothelioma (MPM) (NEMO): A double-blind randomized phase II trial (EORTC-08112-LCG)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have